Have experience with Drugdu Technology Co., Ltd? Be the first to leave a review.
[Specification] After reconstitution in vial form, each 0.5 ml/dose contains Hepatitis A live attenuated vaccine ≥ 6.5 LgCCID50 [Route of Administration] Subcutaneous injection [Shelf life] 24 months [Highlights] •H2 strain is recognized by WHO •Only one dose is needed to provide sufficient... Read more »
As a global leading pharmaceuticals and medical devices online platform, Drugdu(Ddu) is dedicated to accelerating cross-border trading of medical products. Now we have established distribution channels for over 100,000 suppliers and buyers within worldwide, providing business opportunities and... Read more »
For thrombocytopenia induced by radiotherapy and chemotherapy for cancer patients Read more »
Product Information Dosage Form:Injection Route of Administration:Intramuscular Injection Shelf Life:3 years Storage:2℃-8℃ Qualification: Chinese GMP Description [Quality standard] Company Standard (YBS01402011) [Suitable population] This product is suitable for susceptible population aged 16... Read more »
[Specification]0.5ml per container.0.5 ml per single human dose containing 10 μg of HBsAg. [Eligibles]The subjects susceptible to hepatitis B virus, under 16 years of age, especially newborns born to HBsAg and/to HBeAg-positive mothers [Action and use]The product can induce immunity against... Read more »
Let users know what you would have wanted to know about this company.